Eli Lillys blockbuster weight loss injections Zepbound and Mounjaro, which features the active ingredient tirzepatide, targets both GLPR and GLP-1 receptors for weight management
Compared to pioglitazone treatment, rosiglitazone increases the risk of AMI and heart failure in type 2 diabetic patients and elderly patients [222,223,224]
After a full-text review of 33 articles, 14 randomized controlled trials (RCTs) were ultimately included in the analysis [26,27,28,29,30,31,32,33,34,35,36,37,38,39]
By working on multiple metabolic pathways simultaneously, it supports significant and sustained weight loss while promoting overall metabolic health, with personalized dosing and medical guidance
Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials
Multifactorial mechanism of sarcopenia and sarcopenic obesity